Skip to main content

Table 4 Laboratory tests of all enrolled patients after admission

From: Role of enteral nutrition in nonthyroidal illness syndrome: a retrospective observational study

Time

Parameters

All subjects (N = 80)

Group A (N = 66)

Group B (N = 14)

P-valuea

P-valueb

Baseline

WBC, ×109/L, mean ± SD

10.35 ± 6.52

10.30 ± 6.31

10.54 ± 1.47

0.785

–

CRP, mg/L, mean ± SD

72.03 ± 54.21

73.53 ± 62.11

71.82 ± 25.11

0.496

–

RBC, ×109/L, mean ± SD

3.17 ± 0.68

3.21 ± 0.73

3.16 ± 0.54

0.389

–

GPT, U/L, mean ± SD

45.21 ± 28.03

46.62 ± 25.36

44.27 ± 17.96

0.443

–

PCs, ×109/L, mean ± SD

124.67 ± 62.42

126.48 ± 82.38

122.66 ± 78.53

0.453

–

Cr, umol/L, mean ± SD

54.78 ± 54.11

56.28 ± 49.98

53.50 ± 34.59

0.557

–

Week 1

WBC, ×109/L, mean ± SD

9.87 ± 5.17

9.89 ± 5.34

9.35 ± 3.47

0.745

0.466

CRP, mg/L, mean ± SD

42.58 ± 27.47

43.61 ± 28.18

40.91 ± 11.85

0.058

0.022

RBC, ×109/L, mean ± SD

3.19 ± 0.72

3.20 ± 0.78

3.18 ± 0.17

0.177

0.597

GPT, U/L, mean ± SD

36.01 ± 22.28

37.82 ± 13.51

35.29 ± 10.83

0.581

0.180

PCs, ×109/L, mean ± SD

141.81 ± 57.02

143.69 ± 52.76

140.11 ± 12.54

0.184

0.388

Cr, umol/L, mean ± SD

52.47 ± 43.73

54.20 ± 19.97

51.86 ± 7.09

0.588

0.806

Week 2

WBC, ×109/L, mean ± SD

10.01 ± 6.13

10.12 ± 7.22

9.89 ± 2.25

0.685

0.631

CRP, mg/L, mean ± SD

28.62 ± 37.38

30.88 ± 23.48

26.69 ± 20.87

0.047

0.017

RBC, ×109/L, mean ± SD

3.21 ± 0.71

3.22 ± 0.23

3.19 ± 0.50

0.472

0. 614

GPT, U/L, mean ± SD

29.12 ± 12.38

30.24 ± 16.57

28.59 ± 14.87

0.841

0.158

PCs, ×109/L, mean ± SD

153.32 ± 37.32

155.54 ± 56.77

151.08 ± 39.52

0.687

0.069

Cr, umol/L, mean ± SD

43.55 ± 27.31

45.13 ± 16.47

42.32 ± 37.54

0.343

0.635

Week 3

WBC, ×109/L, mean ± SD

9.92 ± 4.38

9.96 ± 3.82

9.84 ± 2.87

0.776

0.508

CRP, mg/L, mean ± SD

18.52 ± 10.41

19.13 ± 13.13

18.23 ± 9.33

0.214

0.012

RBC, ×109/L, mean ± SD

3.20 ± 0.85

3.22 ± 0.93

3.19 ± 0.12

0.462

0.607

GPT, U/L, mean ± SD

21.61 ± 9.12

22.47 ± 12.92

20.38 ± 7.23

0.596

0.031

PCs, ×109/L, mean ± SD

176.66 ± 50.56

178.89 ± 67.53

175.12 ± 24.68

0.295

0.045

Cr, umol/L, mean ± SD

37.93 ± 15.09

39.55 ± 10.89

35.23 ± 27.42

0.493

0.431

Week 4

WBC, ×109/L, mean ± SD

9.16 ± 5.23

9.20 ± 7.89

9.12 ± 3.69

0.823

0.383

CRP, mg/L, mean ± SD

14.11 ± 6.17

14.55 ± 7.95

19.39 ± 3.98

0.069

0.005

RBC, ×109/L, mean ± SD

3.22 ± 0.44

3.25 ± 0.59

3.20 ± 0.34

0.406

0.621

GPT, U/L, mean ± SD

18.73 ± 9.91

19.72 ± 8.26

17.87 ± 7.40

0.622

0.010

PCs, ×109/L, mean ± SD

187.53 ± 15.93

189.37 ± 26.71

185.72 ± 42.46

0.641

0.033

Cr, umol/L, mean ± SD

35.64 ± 28.54

37.87 ± 27.95

33.34 ± 18.92

0.838

0.385

  1. WBC white blood cell counts, CRP C-reactive protein, RBC red blood cell counts, PCs platelet counts, GPT glutamic-pyruvic transaminase, Cr blood urine creatinine
  2. a P value is compared between group A and group B
  3. b P value is compared between the index at varied time point and the same index at the baseline among all subjects
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us